Former Trinity College campus company Opsona Therapeutics has landed a further €3 million in funding, which will help finance planned tests on its lead product and boost its treatment potential.

Drug development firm Opsona Therapeutics has raised €33m to fund test work on a product it is developing to help kidney transplant patients amongst others.